JP2023533662A5 - - Google Patents
Info
- Publication number
- JP2023533662A5 JP2023533662A5 JP2022575829A JP2022575829A JP2023533662A5 JP 2023533662 A5 JP2023533662 A5 JP 2023533662A5 JP 2022575829 A JP2022575829 A JP 2022575829A JP 2022575829 A JP2022575829 A JP 2022575829A JP 2023533662 A5 JP2023533662 A5 JP 2023533662A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- rheumatoid arthritis
- use according
- rabeximod
- symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20179277 | 2020-06-10 | ||
| EP20179279.3 | 2020-06-10 | ||
| EP20179239 | 2020-06-10 | ||
| EP20179239.7 | 2020-06-10 | ||
| EP20179279 | 2020-06-10 | ||
| EP20179277.7 | 2020-06-10 | ||
| EP20180706.2 | 2020-06-18 | ||
| EP20180706 | 2020-06-18 | ||
| PCT/EP2021/065697 WO2021250199A1 (en) | 2020-06-10 | 2021-06-10 | Rabeximod in the treatment of rheumatoid arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023533662A JP2023533662A (ja) | 2023-08-04 |
| JP2023533662A5 true JP2023533662A5 (enExample) | 2024-06-17 |
Family
ID=76305939
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022576335A Pending JP2023529001A (ja) | 2020-06-10 | 2021-06-10 | 結晶形のラベキシモドを含む経口製剤 |
| JP2022575226A Pending JP2023529877A (ja) | 2020-06-10 | 2021-06-10 | 結晶形のラベキシモドの調製方法 |
| JP2022575829A Pending JP2023533662A (ja) | 2020-06-10 | 2021-06-10 | 関節リウマチの治療におけるラベキシモド |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022576335A Pending JP2023529001A (ja) | 2020-06-10 | 2021-06-10 | 結晶形のラベキシモドを含む経口製剤 |
| JP2022575226A Pending JP2023529877A (ja) | 2020-06-10 | 2021-06-10 | 結晶形のラベキシモドの調製方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US12594274B2 (enExample) |
| EP (3) | EP4164616A1 (enExample) |
| JP (3) | JP2023529001A (enExample) |
| KR (3) | KR20230022882A (enExample) |
| CN (4) | CN115697308A (enExample) |
| AU (3) | AU2021290174A1 (enExample) |
| CA (3) | CA3181637A1 (enExample) |
| WO (3) | WO2021250199A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023529001A (ja) | 2020-06-10 | 2023-07-06 | シクソン エービー | 結晶形のラベキシモドを含む経口製剤 |
| US11643415B1 (en) * | 2021-12-09 | 2023-05-09 | Cyxone Ab | Rabeximod compounds |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8600260D0 (sv) | 1986-01-21 | 1986-01-21 | Lundblad Leif | Substituerade indolokinoxaliner |
| SE504289C2 (sv) * | 1994-06-23 | 1996-12-23 | Leif J I Lundblad | Användning av vissa indolo-2,3b-kinoxaliner för framställning av ett läkemedel för inhibering av enzymet HIV-integras |
| JPH08165278A (ja) | 1994-12-14 | 1996-06-25 | Kawaken Fine Chem Co Ltd | １−置換トリプタミン化合物の製造方法 |
| SE504862C2 (sv) | 1994-12-27 | 1997-05-20 | Leif J I Lundblad | Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler |
| DE19516804A1 (de) * | 1995-05-08 | 1996-11-14 | Hoechst Ag | Isoindolinpigmente auf Basis von Aminochinoxalindionen |
| SE516067C2 (sv) | 2000-02-18 | 2001-11-12 | Lundblad Leif J I | Användning av en förening för framställning av ett läkemedel |
| US6333327B2 (en) | 2000-02-18 | 2001-12-25 | Leif J. I. Lundblad | Method for the treatment of Multiple Sclerosis |
| TW200410921A (en) * | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
| ATE382623T1 (de) * | 2004-06-09 | 2008-01-15 | Hoffmann La Roche | Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln |
| SE527639C2 (sv) | 2004-06-17 | 2006-05-02 | Oxypharma Ab | Alkylsubstituerade indolokinoxaliner |
| CN101558038B (zh) * | 2006-11-30 | 2013-05-01 | 国立大学法人东京工业大学 | 姜黄素衍生物 |
| CN102115457B (zh) | 2011-03-05 | 2012-11-21 | 太原理工大学 | 一种n-乙基咔唑的制备方法 |
| WO2013182905A2 (en) * | 2012-06-05 | 2013-12-12 | Jonas Axelsson | Mechanism, diagnostic, and treatments for complications of renal failure |
| WO2014140321A1 (en) | 2013-03-15 | 2014-09-18 | Vironova Ab | Antiviral indolo[2,3-b]quinoxaline |
| EP3302442B1 (en) | 2015-06-03 | 2024-10-16 | Triastek, Inc. | Dosage forms and use thereof |
| CN105061432B (zh) | 2015-07-16 | 2017-09-29 | 河北大学 | 6H‑吲哚[2,3‑b]喹喔啉衍生物、药物组合物及其制备和应用 |
| TWI721483B (zh) * | 2018-07-13 | 2021-03-11 | 美商基利科學股份有限公司 | 吡咯并[1,2-b]嗒𠯤衍生物 |
| WO2021250196A1 (en) | 2020-06-10 | 2021-12-16 | Cyxone Ab | New use of rabeximod |
| JP2023529001A (ja) | 2020-06-10 | 2023-07-06 | シクソン エービー | 結晶形のラベキシモドを含む経口製剤 |
| US11643415B1 (en) * | 2021-12-09 | 2023-05-09 | Cyxone Ab | Rabeximod compounds |
-
2021
- 2021-06-10 JP JP2022576335A patent/JP2023529001A/ja active Pending
- 2021-06-10 WO PCT/EP2021/065697 patent/WO2021250199A1/en not_active Ceased
- 2021-06-10 AU AU2021290174A patent/AU2021290174A1/en not_active Abandoned
- 2021-06-10 EP EP21730626.5A patent/EP4164616A1/en active Pending
- 2021-06-10 EP EP21733745.0A patent/EP4165043A1/en active Pending
- 2021-06-10 WO PCT/EP2021/065705 patent/WO2021250204A1/en not_active Ceased
- 2021-06-10 CN CN202180042114.0A patent/CN115697308A/zh active Pending
- 2021-06-10 EP EP21731797.3A patent/EP4164650A1/en active Pending
- 2021-06-10 CN CN202510521204.8A patent/CN120383602A/zh active Pending
- 2021-06-10 KR KR1020227045213A patent/KR20230022882A/ko active Pending
- 2021-06-10 US US18/000,943 patent/US12594274B2/en active Active
- 2021-06-10 US US18/000,945 patent/US12673056B2/en active Active
- 2021-06-10 JP JP2022575226A patent/JP2023529877A/ja active Pending
- 2021-06-10 CA CA3181637A patent/CA3181637A1/en active Pending
- 2021-06-10 AU AU2021290173A patent/AU2021290173A1/en active Pending
- 2021-06-10 WO PCT/EP2021/065694 patent/WO2021250197A1/en not_active Ceased
- 2021-06-10 CA CA3181646A patent/CA3181646A1/en active Pending
- 2021-06-10 AU AU2021289006A patent/AU2021289006A1/en active Pending
- 2021-06-10 CN CN202180041778.5A patent/CN115698010A/zh active Pending
- 2021-06-10 CN CN202180042179.5A patent/CN115768431A/zh active Pending
- 2021-06-10 JP JP2022575829A patent/JP2023533662A/ja active Pending
- 2021-06-10 KR KR1020227045212A patent/KR20230022881A/ko active Pending
- 2021-06-10 CA CA3181629A patent/CA3181629A1/en active Pending
- 2021-06-10 KR KR1020227045211A patent/KR20230022880A/ko active Pending
- 2021-12-22 US US17/559,057 patent/US20220133717A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kamen et al. | A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury | |
| JP6419195B2 (ja) | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 | |
| Ventafridda et al. | Non-steroidal antiinflammatory drugs as the first step in cancer pain therapy: double-blind, within-patient study comparing nine drugs | |
| JP2010518021A (ja) | Ｓ−アデノシルメチオニンの持続放出医薬製剤 | |
| RU2322262C2 (ru) | Композиции нестероидных противовоспалительных лекарственных средств, противозастойных средств и антигистаминов | |
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| JP2013010783A (ja) | 便秘患者におけるシメチコンの使用 | |
| WO2005004915A2 (en) | Compositions comprising meloxicam | |
| Plänitz | Comparison of moxonidine and clonidine HCl in treating patients with hypertension | |
| US20100113453A1 (en) | Sublingual Formulations of D-Cycloserine and Methods of Using Same | |
| WO2016120787A1 (en) | Oral n-acetylcysteine in the treatment of upper respiratory tract infections and symptoms | |
| KR20190086712A (ko) | 리도카인-비유효 병태 및 저칼륨혈성 병태의 치료를 위한 요법 | |
| US20220168318A1 (en) | Pharmaceutical compositions and methods for treatment of insomnia | |
| EP4478887A1 (en) | Novel pharmaceutical compositions and methods for treatment of insomnia | |
| JP2002523363A5 (enExample) | ||
| JP2023533662A (ja) | 関節リウマチの治療におけるラベキシモド | |
| JPH05201861A (ja) | デキストロメトルフアンの鎮咳効果の増強 | |
| CN107519176A (zh) | 防治运动病、梅尼埃病的药物及莫扎伐普坦的医药用途 | |
| CN108478581A (zh) | 防治运动病、梅尼埃病的药物及托伐普坦的医药用途 | |
| JP2000229853A (ja) | 生理痛改善用組成物 | |
| CN104906501A (zh) | 治疗银屑病的中药组分组合物 | |
| Keet | A comparative clinical trial of diflunisal and ibuprofen in the control of pain in osteoarthritis | |
| Gordin et al. | Comparison of a slow-release indomethacin tablet and naproxen in osteoarthrosis | |
| Skoner | Montelukast in 2‐to 5‐year‐old children with asthma | |
| JP2008044879A (ja) | ラクトフェリンを含有する医薬組成物ならびに加工食品 |